GlobeNewsWire
06 Aug 2026, 19:46 UTC · 12w ago
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed ARS Pharmaceutic (SPRY)
Impact · against what's priced in
The filing of a securities class action lawsuit against ARS Pharmaceuticals (SPRY) creates additional legal overhead and management distraction. While the stock already plummeted on the news of the CVS Caremark coverage delay, the formal litigation adds a layer of settlement risk and regulatory scrutiny.
- SPRY−0.20
No priced-in read yet





